Industry: Biotechnology Region: France Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A French biotechnology and safety assessment agency, established in 2021 and headquartered in Rennes Bio-Park, provides comprehensive and innovative alternative solutions for customers in different industries such as cosmetics, pharmaceuticals, agricultural food and environment to test the safety and effectiveness of regulations. The company has created an AI-driven solution that integrates computer simulation, in vitro and in vivo methods to evaluate the safety and effectiveness of ingredients, chemicals and products. With the help of AI and computer simulation technology, it can provide fast and reliable technical solutions for its customers.
Introduction to enterprise services:
1. Safety evaluation of ingredients and formula
Predict and analyze the potential risks of raw materials, molecules or formulas, including irritation, sensitization, absorption characteristics, etc., and form professional evaluation documents and technical instructions that meet the requirements of industry regulations.
2. In vitro experimental test
Evaluation of safety and biological response based on cell or tissue model can cover many standardized tests such as skin irritation, sensitivity and penetration.
3. Calculation model prediction
Using digital model to quickly predict molecular characteristics, toxicological risks, efficacy trends, etc. It is used to screen raw materials in the early stage of products and reduce research and development time and cost.
Cooperation mode:
Looking for partners who need product composition evaluation services in the fields of cosmetics, pharmaceuticals and agriculture.